Search - tctmd.com

Displaying 221 - 240 of 694

Sort: Relevancy | Date

News Conference News TCT 2019

Safe to Drop P2Y12 Inhibitor at 3 Months in High-Bleeding-Risk Patients: EVOLVE Short DAPT

Caitlin E. Cox

September 26, 2019

Presentation TCT 2019

Clinical Trial Design Considerations for Next-to-Market and Next-Generation LAAO Devices

Presenter: Brian Whisenant

September 26, 2019

Presentation TCT 2019

Experience on the Early Feasibility Study (US Industry’s View)

Presenter: Robert Thatcher

September 26, 2019

Presentation TCT 2019

Making the Case for… - Surgical Perspectives: Not So Fast, We Need a Randomized Trial!

Presenter: Patrick McCarthy

September 26, 2019

Presentation TCT 2019

Making the Case for… - Case Presentation, Rationale, and UNLOAD Trial Updates

Presenter: Nicolas van Mieghem

September 26, 2019

Presentation TCT 2019

Making the Case for… - Rationale and Trial Updates

Presenter: Philippe Genereux

September 26, 2019

Presentation TCT 2019

Making the Case for… - Clinical Trial Updates, Anatomic Considerations, and Optimizing Procedural Outcomes

Presenter: Raj Makkar

September 26, 2019

Presentation TCT 2019

Experience on the Global Clinical Trial (Japanese Industry’s View)

Presenter: Daiki Yasuhara

September 26, 2019

Presentation TCT 2019

The Basic Regulation Pathway For an Early Feasibility Study in the US

Presenter: Hiren Mistry

September 26, 2019

Presentation TCT 2019

The Basic Regulation Pathway For a Clinical Trial in Japan Compared to US Regulation

Presenter: Mitsuru Yuba

September 26, 2019

Presentation TCT 2019

FDA Pivotal Clinical Trial Design and Beyond

Presenter: Ori Ben-Yehuda

September 26, 2019

News TCT 2019

TCT 2019 Day One: TWILIGHT and Onyx ONE Kick Things Off

Shelley Wood

September 26, 2019

News Conference News TCT 2019

AUGUSTUS: Apixaban-Based Dual Therapy Best Across Major Subgroups

Todd Neale

September 26, 2019

News Conference News TCT 2019

Onyx ONE: Shorter DAPT Plus ZES Noninferior to Polymer-Free Stent in High-Bleeding-Risk Patients

L.A. McKeown

September 26, 2019

https://www.tctmd.com/news/ideal-lm-probes-short-dapt-and-bioabsorbable-polymer-stent-left-main-disease

News Conference News TCT 2019

IDEAL-LM Probes Short DAPT and a Bioabsorbable-Polymer Stent in Left Main Disease

Michael O'Riordan

September 26, 2019

News Conference News TCT 2019

TWILIGHT: Ticagrelor Monotherapy Lowers Bleeding Without Increasing Ischemic Events

Yael L. Maxwell

September 26, 2019

Presentation TCT 2019

Polymer-Free DES: Lessons Learned From Recent Trials

Presenter: Michael Maeng

September 26, 2019

Presentation TCT 2019

Biodegradable Polymer DES: Do Clinical Trial Data Support Claims of Superior Safety or Effectiveness?

Presenter: Takeshi Kimura

September 26, 2019

Presentation TCT 2019

Clinical Trial Snapshots: Top DES Randomized Trials of the Last 2 Years

Presenter: Mamas Mamas

September 26, 2019

News Conference News TCT 2019

Personalized CT-Derived Modeling Guides Choices in Bicuspid Aortic Valve Disease

Michael O'Riordan

September 25, 2019

Advertisement

Safe to Drop P2Y12 Inhibitor at 3 Months in High-Bleeding-Risk Patients: EVOLVE Short DAPT

Clinical Trial Design Considerations for Next-to-Market and Next-Generation LAAO Devices

Experience on the Early Feasibility Study (US Industry’s View)

Making the Case for… - Surgical Perspectives: Not So Fast, We Need a Randomized Trial!

Making the Case for… - Case Presentation, Rationale, and UNLOAD Trial Updates

Making the Case for… - Rationale and Trial Updates

Making the Case for… - Clinical Trial Updates, Anatomic Considerations, and Optimizing Procedural Outcomes

Experience on the Global Clinical Trial (Japanese Industry’s View)

The Basic Regulation Pathway For an Early Feasibility Study in the US

The Basic Regulation Pathway For a Clinical Trial in Japan Compared to US Regulation

FDA Pivotal Clinical Trial Design and Beyond

TCT 2019 Day One: TWILIGHT and Onyx ONE Kick Things Off

AUGUSTUS: Apixaban-Based Dual Therapy Best Across Major Subgroups

Onyx ONE: Shorter DAPT Plus ZES Noninferior to Polymer-Free Stent in High-Bleeding-Risk Patients

IDEAL-LM Probes Short DAPT and a Bioabsorbable-Polymer Stent in Left Main Disease

TWILIGHT: Ticagrelor Monotherapy Lowers Bleeding Without Increasing Ischemic Events

Polymer-Free DES: Lessons Learned From Recent Trials

Biodegradable Polymer DES: Do Clinical Trial Data Support Claims of Superior Safety or Effectiveness?

Clinical Trial Snapshots: Top DES Randomized Trials of the Last 2 Years

Personalized CT-Derived Modeling Guides Choices in Bicuspid Aortic Valve Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content